These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

310 related articles for article (PubMed ID: 21188448)

  • 21. Multitarget therapy versus intravenous cyclophosphamide in the induction treatment of lupus nephritis: a metaanalysis of randomized controlled trials.
    Deng J; Luo L; Zhu L; Xie H; xie H
    Turk J Med Sci; 2018 Oct; 48(5):901-910. PubMed ID: 30384552
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Tacrolimus for induction therapy of diffuse proliferative lupus nephritis: an open-labeled pilot study.
    Mok CC; Tong KH; To CH; Siu YP; Au TC
    Kidney Int; 2005 Aug; 68(2):813-7. PubMed ID: 16014060
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Tacrolimus for the treatment of systemic lupus erythematosus with pure class V nephritis.
    Szeto CC; Kwan BC; Lai FM; Tam LS; Li EK; Chow KM; Gang W; Li PK
    Rheumatology (Oxford); 2008 Nov; 47(11):1678-81. PubMed ID: 18753192
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Efficacy and safety of mycophenolate mofetil and tacrolimus combination therapy in patients with lupus nephritis: a nationwide multicentre study.
    Park DJ; Kang JH; Lee KE; Bae SC; Chung WT; Choe JY; Jung SY; Kim YS; Lee HS; Lee J; Lee YA; Park SH; Park YJ; Suh CH; Yoo DH; Lee SS
    Clin Exp Rheumatol; 2019; 37(1):89-96. PubMed ID: 29998829
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Tacrolimus is effective for lupus nephritis patients with persistent proteinuria.
    Uchino A; Tsukamoto H; Nakashima H; Yoshizawa S; Furugo I; Mitoma H; Oryoji K; Shimoda T; Niiro H; Tada Y; Yano T; Nonaka T; Oishi R; Akashi K; Horiuchi T
    Clin Exp Rheumatol; 2010; 28(1):6-12. PubMed ID: 20346231
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Interaction between everolimus and tacrolimus in renal transplant recipients: a pharmacokinetic controlled trial.
    Pascual J; del Castillo D; Cabello M; Pallardó L; Grinyó JM; Fernández AM; Brunet M
    Transplantation; 2010 Apr; 89(8):994-1000. PubMed ID: 20335831
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Efficacy and safety of tacrolimus for lupus nephritis: a placebo-controlled double-blind multicenter study.
    Miyasaka N; Kawai S; Hashimoto H
    Mod Rheumatol; 2009; 19(6):606-15. PubMed ID: 19688181
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Efficacy and safety of tacrolimus in induction therapy of patients with lupus nephritis.
    Zhou T; Lin S; Yang S; Lin W
    Drug Des Devel Ther; 2019; 13():857-869. PubMed ID: 30880918
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Tacrolimus versus cyclophosphamide in steroid-dependent or steroid-resistant focal segmental glomerulosclerosis: a randomized controlled trial.
    Ren H; Shen P; Li X; Pan X; Zhang W; Chen N
    Am J Nephrol; 2013; 37(1):84-90. PubMed ID: 23343906
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of renal response to four different induction therapies in Japanese patients with lupus nephritis class III or IV: A single-centre retrospective study.
    Hanaoka H; Kiyokawa T; Iida H; Ishimori K; Takakuwa Y; Okazaki T; Yamada H; Ichikawa D; Shirai S; Koike J; Ozaki S
    PLoS One; 2017; 12(4):e0175152. PubMed ID: 28384208
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mizoribine, tacrolimus, and corticosteroid combination therapy successfully induces remission in patients with lupus nephritis.
    Kagawa H; Hiromasa T; Hara T; Takaki A; Yamanaka R; Sada KE; Makino H
    Clin Exp Nephrol; 2012 Oct; 16(5):760-6. PubMed ID: 22492013
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Sustained remission of lupus nephritis.
    Barber CE; Geldenhuys L; Hanly JG
    Lupus; 2006; 15(2):94-101. PubMed ID: 16539280
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A randomized, controlled double-blind study comparing the efficacy and safety of dose-ranging voclosporin with placebo in achieving remission in patients with active lupus nephritis.
    Rovin BH; Solomons N; Pendergraft WF; Dooley MA; Tumlin J; Romero-Diaz J; Lysenko L; Navarra SV; Huizinga RB;
    Kidney Int; 2019 Jan; 95(1):219-231. PubMed ID: 30420324
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Short-term outcomes of induction therapy with tacrolimus versus cyclophosphamide for active lupus nephritis: A multicenter randomized clinical trial.
    Chen W; Tang X; Liu Q; Chen W; Fu P; Liu F; Liao Y; Yang Z; Zhang J; Chen J; Lou T; Fu J; Kong Y; Liu Z; Fan A; Rao S; Li Z; Yu X
    Am J Kidney Dis; 2011 Feb; 57(2):235-44. PubMed ID: 21177013
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Lack of partial renal response by 12 weeks after induction therapy predicts poor renal response and systemic damage accrual in lupus nephritis class III or IV.
    Hanaoka H; Yamada H; Kiyokawa T; Iida H; Suzuki T; Yamasaki Y; Ooka S; Nagafuchi H; Okazaki T; Ichikawa D; Shirai S; Shibagaki Y; Koike J; Ozaki S
    Arthritis Res Ther; 2017 Jan; 19(1):4. PubMed ID: 28086993
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prognosis of proliferative lupus nephritis subsets in the Louvain Lupus Nephritis inception Cohort.
    Vandepapelière J; Aydin S; Cosyns JP; Depresseux G; Jadoul M; Houssiau FA
    Lupus; 2014 Feb; 23(2):159-65. PubMed ID: 24300780
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The efficacy of add-on tacrolimus for minor flare in patients with systemic lupus erythematosus: a retrospective study.
    Watanabe H; Yamanaka R; Sada KE; Zeggar S; Katsuyama E; Katsuyama T; Narazaki MT; Tatebe NT; Sugiyama K; Watanabe KS; Wakabayashi H; Kawabata T; Wada J; Makino H
    Lupus; 2016 Jan; 25(1):54-60. PubMed ID: 26296361
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Tacrolimus use in lupus nephritis: A systematic review and meta-analysis.
    Hannah J; Casian A; D'Cruz D
    Autoimmun Rev; 2016 Jan; 15(1):93-101. PubMed ID: 26427983
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Rituximab vs mycophenolate and vs cyclophosphamide pulses for induction therapy of active lupus nephritis: a clinical observational study.
    Moroni G; Raffiotta F; Trezzi B; Giglio E; Mezzina N; Del Papa N; Meroni P; Messa P; Sinico AR
    Rheumatology (Oxford); 2014 Sep; 53(9):1570-7. PubMed ID: 24505125
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The prognosis of biopsy-proven lupus nephritis in chinese patients: long term follow-up of 86 cases.
    Shen K; Yu Y; Tang Z; Liu Z; Li L
    Chin Med J (Engl); 1997 Jul; 110(7):502-7. PubMed ID: 9594205
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.